Novel plasma and brain proteins that are implicated in multiple sclerosis
Brain · 2023
DOI: 10.1093/brain/awac420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Xin Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Menzies Institute for Medical Research, University of Tasmania, Hobart 7000, Australia. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Medical Research Council, MS Research Australia, Medical Research Future Fund.
Abstract (Originalsprache)
Understanding how variations in the plasma and brain proteome contribute to multiple sclerosis susceptibility can provide important insights to guide drug repurposing and therapeutic development for the disease. However, the role of genetically predicted protein abundance in multiple sclerosis remains largely unknown. Integrating plasma proteomics (n = 3301) and brain proteomics (n = 376 discovery; n = 152 replication) into multiple sclerosis genome-wide association studies (n = 14 802 cases and 26 703 controls), we employed summary-based methods to identify candidate proteins involved in multiple sclerosis susceptibility. Next, we evaluated associations of the corresponding genes with multiple sclerosis at tissue-level using large gene expression quantitative trait data from whole-blood (n = 31 684) and brain (n = 1194) tissue. Further, to assess transcriptional profiles for candidate proteins at cell-level, we examined gene expression patterns in immune cell types (Dataset 1: n = 73 cases and 97 controls; Dataset 2: n = 31 cases and 31 controls) for identified plasma proteins, and in brain cell types (Dataset 1: n = 4 cases and 5 controls; Dataset 2: n = 5 cases and 3 controls) for identified brain proteins. In a longitudinal multiple sclerosis cohort (n = 203 cases followed up to 15 years), we also assessed the corresponding gene-level associations with the outcome of disability worsening. We identified 39 novel proteins associated with multiple sclerosis risk. Based on five identified plasma proteins, four available corresponding gene candidates showed consistent associations with multiple sclerosis risk in whole-blood, and we found TAPBPL upregulation in multiple sclerosis B cells, CD8+ T cells and natural killer cells compared with controls. Among the 34 candidate brain proteins, 18 were replicated in a smaller cohort and 14 of 21 available corresponding gene candidates also showed consistent associations with multiple sclerosis risk in brain tissue. In cell-specific analysis, six identified brain candidates showed consistent differential gene expression in neuron and oligodendrocyte cell clusters. Based on the 39 protein-coding genes, we found 23 genes that were associated with disability worsening in multiple sclerosis cases. The findings present a set of candidate protein biomarkers for multiple sclerosis, reinforced by high concordance in downstream transcriptomics findings at tissue-level. This study also highlights the heterogeneity of cell-specific transcriptional profiles for the identified proteins and that numerous candidates were also implicated in disease progression. Together, these findings can serve as an important anchor for future studies of disease mechanisms and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Menzies Institute for Medical Research, University of Tasmania, Hobart 7000, Australia.
- Mater Research Institute, Translational Research Institute, South Brisbane 4101, Australia.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072, Australia.
- Department of Medicine, University of Melbourne, Melbourne 3010, Australia.
- Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne 3052, Australia.
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne 3800, Australia.
ORCID-Profile: Xin Lin, Valery Fuh-Ngwa, Kathryn P Burdon
Förderung
- Medical Research Council
- MS Research Australia
- Medical Research Future Fund
- Australian National Health
- Australian National Health and Medical Research Council Research Fellowship
- Henry Baldwin Trust and the Medical Research Future Fund
- Multiple Sclerosis Research Australia Fellowship
- Mater Foundation
Zitieren
APA
Lin, X., Yang, Y., Gresle, M., Cuellar-Partida, G., Han, X., Stankovich, J., AusLong/Ausimmune Investigators Group, Simpson-Yap, S., Fuh-Ngwa, V., Charlesworth, J., Burdon, K. P., Butzkueven, H., Taylor, B. V., & Zhou, Y. (2023). Novel plasma and brain proteins that are implicated in multiple sclerosis. Brain. https://doi.org/10.1093/brain/awac420
Vancouver
Lin X, Yang Y, Gresle M, Cuellar-Partida G, Han X, Stankovich J, et al. Novel plasma and brain proteins that are implicated in multiple sclerosis. Brain. 2023. doi:10.1093/brain/awac420
BibTeX
@article{Lin2023,
author = {Lin, Xin and Yang, Yuanhao and Gresle, Melissa and Cuellar-Partida, Gabriel and Han, Xikun and Stankovich, Jim and AusLong/Ausimmune Investigators Group, AusLong/Ausimmune Investigators Group and Simpson-Yap, Steve and Fuh-Ngwa, Valery and Charlesworth, Jac and Burdon, Kathryn P and Butzkueven, Helmut and Taylor, Bruce V and Zhou, Yuan},
title = {Novel plasma and brain proteins that are implicated in multiple sclerosis},
journal = {Brain},
year = {2023},
doi = {10.1093/brain/awac420}
}
EUVIMED